The Institute of Cancer Research sustainability score: 50/100

HESA EMR 2023/24 (statutory, independent verification) reports 4,808.9 tCO₂e combined Scope 1+2, a 41% reduction versus 2005 baseline. Methodology aligned to GHG Protocol. No separate third-party limited assurance of ICR's own sustainability report was identified, preventing higher score.

ICR publicly acknowledges Scope 3 procurement (lab consumables, equipment) comprises >90% of total emissions. Sustainable Procurement Strategy developed; supplier engagement underway. No quantified Scope 3 inventory in tonnes CO₂e published. Cancer research supply chains involve material global lab procurement with unknown footprint.

HESA EMR shows 41% absolute reduction Scope 1+2 versus 2005 and −44.8% carbon intensity over 10 years. Infrastructure upgrades (solar, electric autoclaves) confirmed. Scope 3 trajectory—representing >90% of emissions—not tracked or published, preventing full carbon trajectory assessment.

100% green-tariff renewable electricity purchased; 0.5% on-site solar generation. Switched to nuclear when renewable tariffs became expensive post-Brexit, maintaining HESA green classification but departing from certified renewable. Nuclear is low-carbon but not renewable. Energy intensity 581.3 kWh/m², typical for laboratory research.

Two urban campuses with green space stewardship; staff volunteer with Sutton Council on wildflower diversity and Big Butterfly Count. Pollards Wood under evaluation for enhancement. No TNFD disclosure, no quantified nature footprint, no deforestation-free supply chain commitment identified. Lab consumables and equipment carry embedded nature impacts unassessed.

HESA EMR 2023/24: 183 kg/FTE waste, 39.6% recycling rate—below ICR's 50% target by end-2025. Total waste declining year-on-year. Quantified targets: 4.2% annual reduction, 50% recycling by 2025. My Green Lab participation, LEAF accreditation in some labs. Royal Society of Chemistry Sustainable Laboratories grant awarded March 2025 for glove recycling research.

HESA EMR 2023/24: 15.5 m³/FTE (~21,300 m³ total). Formal target: 10% reduction per ICR member by 2029/30, monitored quarterly. ICR acknowledges UK water stress and lab process demands. No water pollution incidents identified. No independently verified water footprint or watershed engagement programme found.

Net zero by 2040 with ≥90% absolute reduction; interim 42% building emissions reduction by 2030. Described as science-based but not registered with SBTi or equivalent third party. Specific, measurable, tied to decarbonisation plan with annual reporting. No heavy offset reliance. Scope 3 (>90% of emissions) has no quantified target.

Annual Sustainability Report (2023/24 available) structured around Sustainable Discoveries four-pillar plan. Dedicated sustainability capacity (Watts Sustainability engaged). CEO signed Concordat for Environmental Sustainability of Research Innovation publicly. Board oversight in annual statements. HESA EMR statutory submission provides independent data. No third-party limited assurance. No TCFD or CSRD disclosure.

No environmental controversies, regulatory actions, greenwashing complaints, or climate lobbying activity found in InfluenceMap, journalism, NGO reports, or regulatory databases. Exempt charity, specialist cancer research institution with no fossil-sector exposure. Participates positively in sector sustainability through Environmental Sustainability Concordat and CRUK-aligned frameworks.